Sofia Kenin meets Aryna Sabalenka to open play in the China Open in Beijing, China (in the round of 64). In the Abierto Guadalajara (her last tournament), she made the semifinals before falling to Caroline Dolehide. Kenin is +6600 to win this tournament at National Tennis Center.

Find all the latest odds for the 2023 China Open and place your bets with a new user bonus from BetMGM.

Sportsbook Promo Codes

Kenin at the 2023 China Open

  • Next Round: Round of 64
  • Tournament Dates: September 29 - October 8
  • Venue: National Tennis Center
  • Location: Beijing, China
  • Court Surface: Hard

Watch live sports without cable! Sign up today for a free trial to Fubo!

Kenin's Next Match

In the round of 64 of the China Open, on Sunday, October 1 (at 1:45 AM ET), Kenin will play Sabalenka.

Kenin currently has odds of +333 to win her next contest against Sabalenka. Check out the latest odds for the entire field at BetMGM.

Want to bet on Kenin? Head to BetMGM using our link for a bonus bet special offer for new players!

Kenin Stats

  • Kenin last played on September 22, 2023, a 5-7, 3-6 defeat by No. 111-ranked Dolehide in the semifinals of the Abierto Guadalajara.
  • Through 18 tournaments over the past year, Kenin is yet to win a title, and her overall record is 25-18.
  • Kenin is 17-12 on hard courts over the past year.
  • Kenin has played 21.6 games per match in her 43 matches over the past 12 months across all court types.
  • Kenin, in 29 matches over the past year on hard courts, has played 22.0 games per match and won 53.8% of them.
  • When it comes to serve/return winning percentages over the past year, Kenin has won 71.9% of her games on serve, and 35.2% on return.
  • On hard courts, Kenin, over the past year, has claimed 72.5% of her service games and 35.1% of her return games.

Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER.